Investor Relations

Towers Watson is a public company traded on the NASDAQ Stock Market (NASDAQ: TW). We are a leading global professional services company that helps organizations improve performance through effective people, financial and risk management. With more than 15,000 associates around the world, we offer consulting, technology and solutions in the areas of benefits, talent management, rewards, and risk and capital management.

Stock Report

Price $123.00 Data as of 01/04/164:15 p.m. ET
Minimum 20 minute delay

ExchangeNASDAQ (US Dollar)
Change (%) Stock is Down 5.46 (4.25%)
Intraday High$127.39
Intraday Low$122.88
Willis Group S-4/A, October 13, 2015Towers Watson 2015 10-K
Towers Watson 2015 10-K/A

Jan 4, 2016Corporate Pension Plan Funding Levels Showed Little Change in 2015, Towers Watson Analysis Finds
Year-end funded status remained unchanged due to rising rates offset by a weak stock market ARLINGTON, Va.--(BUSINESS WIRE)--Jan. 4, 2016-- The pension funded status of the nation’s largest corporate plan sponsors finished the year unchanged compared with the end of 2014, due in large part to a rise in interest rates mostly offset by a weak global stock market, according to a new analysis by global professional services company Towers Watson (... 
Printer Friendly Version
Dec 24, 2015Towers Watson Announces Special Dividend
ARLINGTON, Va.--(BUSINESS WIRE)--Dec. 24, 2015-- Towers Watson & Co. (NASDAQ:TW), a global professional services company, today announced that the company has declared a one-time special cash dividend of $10.00 per share to Towers Watson stockholders of record as of the close of business on December 29, 2015, in connection with the previously announced merger transaction between Towers Watson and Willis Group Holdings Public Limited Company, subject to t... 
Printer Friendly Version
Dec 15, 2015Employers Take Aim to Curb High Cost of Pharmacy Benefits
New specialty drugs, increasing use of compounds, leads to sharp rise in prescription drug spending ARLINGTON, Va.--(BUSINESS WIRE)--Dec. 15, 2015-- With the availability of expensive new specialty drugs* and a rise in the use of compound drugs, employers are facing a rapid increase in prescription drug spend that makes it more difficult to control rising health care costs. In response, employers are taking specific action now and over the nex... 
Printer Friendly Version
Dec 14, 2015Pension Funds Benefit From Bank Stress Tests
Towers Watson clients have allocated over $7 billion to illiquid credit investment strategies ARLINGTON, Va.--(BUSINESS WIRE)--Dec. 14, 2015-- Institutional investors are exploiting the illiquid credit space vacated by banks facing stricter regulation and ongoing stress tests, according to global professional services company Towers Watson (NASDAQ: TW). The company’s clients have allocated over $7 billion to illiquid credit investment strategi... 
Printer Friendly Version
Upcoming Events
There are currently no events scheduled.
Data provided by Nasdaq. Minimum 15 minutes delayed.